Leukocytoclastic vasculitis (LCV), also termed hypersensitivity vasculitis, is a small-vessel vasculitis with a reported incidence rate of about 30 cases per million people per year and is thought to affect men and women in equal numbers.
Multiple etiologic factors including drugs, infections, foods, autoimmune diseases, collagen vascular diseases, and malignancies have been associated with LCV. 1 Although the exact pathogenic mechanism remains to be elucidated, circulating immune complexes are believed to be involved. 6 In the evaluation of patients with LCV, laboratory tests including a complete blood count, erythrocyte sedimentation rate, biochemistry profile with liver and renal function, and urinalysis are useful in excluding other vasculitides, determining the presence of systemic disease, and identifying an associated disorder, which can provide prognostic information. 4 Patients with suspected LCV presenting to the Emergency Department may require parenteral analgesics for pain control, and those patients not requiring hospitalization should be referred to a dermatologist upon discharge. Diagnosis of LCV is confirmed on histologic examination of a biopsy from the affected area that demonstrates perivascular and vascular leukocytic infiltrates along with fibrinoid necrosis. 1 Mild, skin-limited LCV does not require treatment apart from rest, elevation of the legs, ice packs to the affected area, and removal or treatment of the inciting cause. 7 Presence of arthralgia or arthritis requires use of nonsteroidal antiinflammatory drugs, or a short course of oral steroids (eg, prednisone or methlprednisolone) at a dose of 1 mg/kg/day for 4 weeks followed by a steroid taper. Most patients respond to such treatment. 8 A single-pulse dose of intravenous corticosteroids (eg, methylprednisolone, 15 mg/kg) may be required, followed by oral corticosteroids in more severe cases. Colchicine has also reportedly been useful in patients with skin and joint symptoms, though success in a small, randomized controlled trial was limited. 9 Colchicine should be used with caution in persons with kidney disease and in pregnant women. Most patients with cutaneous leukocytoclastic vasculitis are treated in an outpatient setting. Inpatient care is needed in patients who have severe systemic vasculitic syndromes and severe organ dysfunction. In the absence of internal involvement, the majority of cases of LCV resolve within weeks to months, with approximately 10% of patients experiencing chronic or recurrent disease. 10 v Figure 1 . Lower extremities of a 31-year-old woman presenting to the Emergency Department. The patient reported several days of arthralgias and a moderately painful, burning rash involving the legs and extending to the lower abdomen, preceded by a viral syndrome.
This image demonstrates nonblanching palpable purpura to the lower extremities with some areas coalescing to form plaques. Findings are consistent with leukocytoclastic vasculitis.
